Immunocore Holdings plc: Vestal Point Capital, LP and Ryan Wilder report shared beneficial ownership of 2,766,868 ADS, representing 5.5% of the class. The percentage is calculated using 50,695,078 shares outstanding as of January 31, 2026 from the company's Form 10-K. The filing states the ADSs are directly held by the Vestal Point Fund and Account and lists the reporting persons' business address. The statement is signed by Ryan Wilder on behalf of Vestal Point Capital, LLC and individually on May 15, 2026.
Positive
None.
Negative
None.
Insights
Passive 13G stake disclosed: 2,766,868 ADS (5.5% of class).
The filing is a Schedule 13G-style disclosure showing shared voting and dispositive power over 2,766,868 ADS, calculated against 50,695,078 shares outstanding as of January 31, 2026. It identifies the investment manager and a related individual as reporting persons.
Ownership is shown as shared power; the filing describes holdings as directly held by the Vestal Point Fund and Account. Cash-flow treatment and any plans to buy or sell are not stated in the provided excerpt; subsequent filings would show changes.
Key Figures
Reported ADS owned:2,766,868 sharesPercent of class:5.5%Shares outstanding (context):50,695,078 shares+1 more
4 metrics
Reported ADS owned2,766,868 sharesAmount beneficially owned by Vestal Point Fund and Account
Percent of class5.5%Calculated using 50,695,078 shares outstanding as of January 31, 2026
Shares outstanding (context)50,695,078 sharesShares outstanding as of January 31, 2026 per Form 10-K
Filing signature dateMay 15, 2026Date the Schedule 13G was signed by Ryan Wilder
"American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share"
American Depository Shares (ADS) are U.S.-listed securities issued by a bank that represent ownership of a specified number of shares in a foreign company, letting investors buy and sell that company in U.S. dollars on U.S. exchanges. They matter because they make it easier to invest in foreign firms—like buying a locally labeled product instead of importing it—affecting liquidity, dividend payments, regulatory disclosure and exposure to currency swings.
beneficially ownedregulatory
"Amount beneficially owned: The information required by Item 4(a) is set forth"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive powerregulatory
"Shared Dispositive Power 2,766,868.00"
Schedule 13Gregulatory
"form_type: SCHEDULE 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Immunocore Holdings plc
(Name of Issuer)
American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share
(Title of Class of Securities)
45258D105
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
45258D105
1
Names of Reporting Persons
Vestal Point Capital, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,766,868.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,766,868.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,766,868.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
45258D105
1
Names of Reporting Persons
Ryan Wilder
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,766,868.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,766,868.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,766,868.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Immunocore Holdings plc
(b)
Address of issuer's principal executive offices:
92 Park Drive Milton Park, Abingdon, Oxfordshire, United Kingdom.
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Vestal Point Capital, LP (the "Investment Manager"), a Delaware limited partnership, and the investment adviser to a certain fund and a managed account (the "Vestal Point Fund and Account"), with respect to the American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share (the "ADS Shares"), of Immunocore Holdings plc (the "Company") directly held by the Vestal Point Fund and Account; and
(ii) Mr. Ryan Wilder ("Mr. Wilder"), the Chief Investment Officer and Managing Partner of the Investment Manager and the Managing Member of Vestal Point Capital, LLC, the general partner of the Investment Manager, with respect to the ADS Shares directly held by the Vestal Point Fund and Account.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 632 Broadway, Suite 602, New York, NY 10012.
(c)
Citizenship:
The Investment Manager is a Delaware limited partnership. Mr. Wilder is a citizen of the United States.
(d)
Title of class of securities:
American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share
(e)
CUSIP Number(s):
45258D105
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 50,695,078 shares, including ADS Shares, outstanding as of January 31, 2026, as reported in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on February 25, 2026.
(b)
Percent of class:
5.5%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a). The Vestal Point Fund and Account have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the ADS Shares reported herein.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Vestal Point Capital, LP
Signature:
/s/ Ryan Wilder
Name/Title:
By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
What stake does Vestal Point Capital report in IMCR?
Vestal Point Capital and Ryan Wilder report shared ownership of 2,766,868 ADS, equal to 5.5% of the class. The percentage is based on 50,695,078 shares outstanding as of January 31, 2026, per the company's Form 10-K.
Who are the reporting persons on this Schedule 13G for IMCR?
The filing is made by Vestal Point Capital, LP (the investment manager) and Ryan Wilder, Chief Investment Officer and Managing Partner. The business address given is 632 Broadway, Suite 602, New York, NY 10012.
How is ownership power described in the IMCR filing?
Ownership is disclosed as shared voting power and shared dispositive power over the 2,766,868 ADS. Sole voting and dispositive power are reported as 0.00 for the reporting persons in the excerpt.
What date and document anchor the outstanding share count used?
The 50,695,078 shares outstanding figure is taken from Immunocore's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and is stated as of January 31, 2026 in the Schedule 13G.
Does the filing state whether the reporting persons control dividend or sale proceeds?
The filing states the Vestal Point Fund and Account have the right to receive or direct receipt of dividends or sale proceeds for the ADSs reported. No further cash-flow details are provided in the excerpt.
